O,O-二甲基磷酰氯
O,O-二甲基磷酰氯结构式
|
常用名 | O,O-二甲基磷酰氯 | 英文名 | Dimethyl chlorophosphate |
|---|---|---|---|---|
| CAS号 | 813-77-4 | 分子量 | 144.49400 | |
| 密度 | 1.34 g/mL at 25ºC(lit.) | 沸点 | 80ºC25 mm Hg(lit.) | |
| 分子式 | C2H6ClO3P | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | >230 °F | |
| 符号 |
GHS05, GHS06 |
信号词 | Danger |
|
(E)-3-Cyanophosphoenolpyruvate, a new inhibitor of phosphoenolpyruvate-dependent enzymes.
Biochemistry 24(26) , 7602-6, (1985) (E)-3-Cyanophosphoenolpyruvate has been synthesized by reacting dimethyl chlorophosphate with the potassium enolate of ethyl cyanopyruvate. The resulting trialkyl ester was deesterified with bromotrimethylsilane followed by potassium hydroxide. Subsequent tre... |
|
|
Interactions and binding energies of dimethyl methylphosphonate and dimethyl chlorophosphate with amorphous silica.
Langmuir 28(30) , 10962-7, (2012) The fundamental interactions of dimethyl methylphosphonate (DMMP) and dimethyl chlorophosphate (DMCP) on amorphous silica nanoparticles have been investigated with transmission infrared spectroscopy and temperature-programmed desorption (TPD). DMMP and DMCP b... |
|
|
Synthesis, in vitro evaluation, and intraocular pressure effects of water-soluble prodrugs of endocannabinoid noladin ether.
J. Med. Chem. 46(23) , 5083-86, (2003) The poor aqueous solubility of 2-arachidonyl glyceryl ether (noladin ether) 2 hinders both pharmacological studies and pharmaceutical development. The synthesized mono- and diphosphate esters of noladin ether (4 and 6) considerably increased the aqueous solub... |